J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1222-1231

  Mukherjee, Sushovita ^a   Feldmesser, Marta ^a   Casadevall, Arturo ^a  

^a Dept of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

MANNAN; MONOCLONAL ANTIBODY; NITRIC OXIDE SYNTHASE; OPSONIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CELL INTERACTION; CELL KILLING; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0029893009     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1222     Document Type: Article

References (16)

1. Currie BP, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 1994;19:1029-33.
2. Levitz SM. Overview of host defenses in fungal infections. Clin Infect Dis 1992;14(suppl 1):S37-42.
3. Graybill JR, Mitchell L, Drutz DJ. Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation. J Infect Dis 1979;140:546-52.
4. Graybill JR. Cell-mediated immunity in cryptococcosis. Cell Immunol 1974;14:12-21.
5. Cauley LK, Murphy JW. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptacoccus neoformans infection. Infect Immun 1979;23:644-51.
6. Cameron ML, Granger DL, Matthews TJ, Weinberg JB. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis 1994;170:60-7.
7. Levitz SM. Macrophage-Cryptococcus interactions. In: Zwilling BS, Eisenstein TK, eds. Macrophage-pathogen interactions. New York: Marcel Dekker, 1994:533-43.
8. Kozel TR, Gotschlich E. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982;129:1675-80.
9. Granger DL, Perfect JR, Durack DT. Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol 1986;136:672-80.
10. Collins HL, Bancroft GJ. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun 1991;59:3883-8.
11. Kozel TR. Opsonization and phagocytosis of Cryptococcus neoformans. Arch Med Res 1993;24:211-8.
12. Kozel TR, Wilson MA, Murphy JW. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans. Infect Immun 1991;59:3101-10.
13. Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis-alpha and granulocyte-macrophage colony stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992;22:1447-54.
14. Macher AM, Bennett JE, Gadek JE, Frank MM. Complement depletion in cryptococcal sepsis. J Immunol 1978;120:1686-90.
15. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991;9:457.
16. Cherniak R Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994;62:1507-12.